Innovate or perish : managing the enduring technology company in the global market
 Format: Book
 Published: Hoboken, N.J. : Wiley, c2007.
 Language: English
 Summary:
In this book for corporate executives and intellectual property managers, Kahn and fellow IP experts discuss how recent legislation affects global innovation issues and recommends strategies to help technology companies adapt to and thrive in these conditions. Issues affecting innovation and IP include the WTO Agreement on Trade-Related Aspects of Intellectual Property R... (see more)
Print
delicious
Duke
Ford Library Stacks HD53 .I557 2007 c.1 Available
 
Authors
Item Description
  • xxxi, 303 p. : ill. ; 24 cm.
  • ISBN: 9780471779308 (cloth)
  • ISBN: 047177930X (cloth)
  • ISBN: 9780471779308
  • OCLC Number: 71348740
Notes
  • Includes bibliographical references and index.
Related Items
DUKE003834056
Table of Contents
  • About the Editor (p. xvii)
  • About the Authors (p. xix)
  • Preface (Henry Chesbrough) (p. xxix)
  • Part 1. Principles of Global Leadership in the Enduring Technology Company (p. 1)
  • 1. The Polymath CEO: Enlightened Leadership for the Enduring Technology Company (Edward Kahn) (p. 3)
  • The Global Picture from a Lofty Perch (p. 3)
  • What's at Stake (p. 6)
  • Restructuring Financial Incentives (p. 8)
  • IP and Business Strategy Must Be Congruent (p. 9)
  • Disintermediation of RD&E (p. 13)
  • Varied Paths of Innovation (p. 15)
  • Open Innovation and Disruptive Technologies (p. 22)
  • Merger Mania vs. Tech Transfer (p. 25)
  • Wide IP Vision as an Antidote to Trolls (p. 27)
  • Sustainability Requires Constant Change (p. 29)
  • Part 2. Intellectual Property Management (p. 31)
  • 2. The IP Toolkit: Maximizing Business Value from Intellectual Property (Edmund Walsh) (p. 33)
  • The First Rule of Value: Intellectual Property Doesn't Do Anything (on Its Own) (p. 33)
  • The Nature of IP Rights (p. 34)
  • Business Actions that Generate Value (p. 35)
  • Beyond Portfolio Mining (p. 36)
  • The Second Rule of Value: Rational People Don't Sue Themselves (p. 39)
  • Threats and Opportunities (p. 40)
  • The Spectrum of Business Models (p. 41)
  • The Third Rule of Value: "Patience and Diligence Remove Mountains" (William Penn) (p. 45)
  • Top-Down and Bottom-Up Execution (p. 46)
  • Conclusion (p. 48)
  • 3. Harvesting New Intellectual Assets: The Role of Business Method Patents and Trade Secrets in Strategic IP Management (Karl Jorda and Wayne Jaeschke) (p. 49)
  • The Fusion of Marketing, Technology, and IP in Integrated IP Management (p. 49)
  • State Street Bank Leads to an Explosion of Financial and E-Commerce Patents (p. 53)
  • The Debate over Patenting Business Methods and Nontechnical Subject Matter (p. 54)
  • Jeffersonian Liberal Encouragement of Innovation (p. 54)
  • The Doomsday Scenario if Nontechnology Patents Are Not Reined In (p. 55)
  • Litigation of Business Methods (p. 57)
  • Using Business Method Patents to Protect Core Market Interests beyond Finance and E-Commerce (p. 58)
  • Major Users (p. 58)
  • Other Users (p. 59)
  • Dovetail Business Method Patents and Trade Secrets (p. 62)
  • The Role and Value of Trade Secrets in Conjunction with Patents (p. 62)
  • Exemplary Trade-Secret Cases (p. 66)
  • Connecting Business and Marketing with Innovation and IP Protection (p. 68)
  • Business, Technical, and IP Partnering to Pollinate the Seeds and Harvest the Fruit (p. 69)
  • Capturing All of the Innovation for Added Shareholder Value (p. 70)
  • 4. Giants Can Be Nimble: The SBC Story (Abha Divine) (p. 73)
  • Shifts in Innovation (p. 73)
  • Valuation of IP Assets (p. 74)
  • IP Management Styles (p. 76)
  • Defend and Protect (p. 76)
  • Develop and Drive (p. 76)
  • Market and Commercialize (p. 77)
  • The SBC Communications Story (p. 79)
  • Organizational Approach (p. 82)
  • Portfolio Management (p. 83)
  • Business Development (p. 87)
  • Finance (p. 92)
  • Legal (p. 96)
  • Operational Controls (p. 98)
  • Operational and Financial Metrics (p. 99)
  • Conclusions (p. 101)
  • 5. Innovation Asset Portfolio: The Intellectual Property Muse Gets an MBA (Damon Matteo) (p. 103)
  • Finding Value in Innovation (p. 104)
  • Moving R&D into Accountability (p. 105)
  • A New Methodology (p. 107)
  • Measures of Value (p. 108)
  • Legal (p. 109)
  • Technical (p. 110)
  • Market (p. 110)
  • Linkages and Dependencies (p. 112)
  • Profit/Revenue (p. 113)
  • Cost (p. 114)
  • Risk (p. 115)
  • Selection of Research Targets (p. 116)
  • Multiple Commercialization Vehicles (p. 119)
  • Part 3. Innovation (p. 123)
  • 6. Innovation Strategy: The Essential Ingredient (Michael Kayat) (p. 125)
  • Introduction (p. 125)
  • Need for Innovation: The Strategy Review (p. 126)
  • Fuel and Guidance for Innovation (p. 127)
  • Nature of Innovation (p. 128)
  • Sources of Innovation (p. 128)
  • Innovation Models (p. 128)
  • Current Issues with Innovation (p. 132)
  • Innovation Value Gap (p. 133)
  • Uncovering New Ideas and Opportunities (p. 134)
  • Patent Portfolio Paradox (p. 135)
  • Best Practices for Strategic IP Management (p. 137)
  • IP Strategies for Disruptive Innovation (p. 137)
  • IP Strategies for Open Innovation (p. 138)
  • IP as a Core Strategic Element (p. 140)
  • IP Portfolio Optimization (p. 142)
  • Executive and Board Support (p. 147)
  • Conclusions (p. 148)
  • 7. Maximizing Innovation Teams: The Internal and External Connection Network (Carsten Wittrup) (p. 149)
  • Case Story (p. 150)
  • New Approach (p. 152)
  • Innovation Teams and Networks (p. 153)
  • Innovation Team Member Selection Criteria (p. 156)
  • Team Function and Roles (p. 158)
  • Team Leader (p. 160)
  • The Connectors (p. 161)
  • Team Communication (p. 161)
  • The Innovation Team Test Drive (p. 162)
  • 8. Road-Mapping Disruptive Technical Threats and Opportunities in Complex, Technology-Based Subsystems: The Sails Methodology (Bruce Vojak and Frank Chambers) (p. 165)
  • Background (p. 165)
  • The Sails Methodology (p. 172)
  • Examples (p. 176)
  • Example 1. Frequency Generation Subsystems in Wireless Communication Super-Systems (p. 176)
  • Example 2. Optical Multiplexing Subsystems in Optical Communication Super-Systems (p. 179)
  • Example 3. High Voltage Electrical Subsystems in Automotive Super-Systems (p. 183)
  • Concluding Observations (p. 185)
  • Acknowledgments (p. 186)
  • Part 4. Partnered Technology and Business Development (p. 187)
  • 9. Open for Business: The Air Products and Chemicals Story (John Tao and Vincent Magnotta) (p. 189)
  • Background on Open Innovation at Air Products and Chemicals, Inc. (p. 189)
  • Process for Needs Identification (p. 190)
  • Partnering Strategies (p. 191)
  • University R&D Alliances (p. 194)
  • Benefits of Industry-University Research Projects (p. 194)
  • Foundations for Success (p. 196)
  • Intellectual Property Rights (p. 197)
  • Compensation (p. 199)
  • Publication and Secrecy (p. 202)
  • Other Issues (p. 203)
  • Global R&D Insourcing (p. 204)
  • Experience in Russia (p. 204)
  • Experience in China (p. 206)
  • External Providers (p. 208)
  • Partnering with the Government (p. 209)
  • Licensing-In (p. 211)
  • Joint Development (p. 211)
  • Measuring External R&D Programs (p. 212)
  • Recognizing External Technologists or Partners (p. 214)
  • Appendix 9A. Determining Fair Royalty Rates for University-Developed Technology Exclusive License Option (p. 215)
  • Profitability of Air Products (APD) and Companies in Our Chemicals Market Segment (p. 215)
  • University and Corporate Costs of Product R&D and Commercialization (p. 216)
  • Approach 1. Royalty Rate as Function of Sales for Early-Stage Technology (p. 218)
  • Approach 2. Royalty Rates Based on Earnings for Early Stage Technology (p. 220)
  • Conclusion (p. 222)
  • 10. Developing Growth Strategies Using Intellectual Assets and Strategic Alliances (Dennis McCullough) (p. 223)
  • The Importance of Business Growth (p. 223)
  • SBUs as a Growth Vehicle (p. 224)
  • Tale of an SBU: Three Guys in a Garage (p. 225)
  • Lummus Process Technology (p. 229)
  • LPT's Strategy for Growth (p. 229)
  • How Can a Small Technology-Based Business Be a Growth Engine? (p. 230)
  • LPT History (p. 230)
  • Strategic Alliances for Small Business Unit Growth (p. 236)
  • The Key Alliance Success Factors (p. 241)
  • In a Nutshell (p. 243)
  • 11. Innovation and the Biopharmaceutical Industry: Crisis or Crossroads? (Ronald Lindsay) (p. 245)
  • Introduction (p. 246)
  • Current Woes of the Pharmaceutical Industry (p. 247)
  • The Broken Pipeline (p. 247)
  • From Paragon of Virtue to Pariah in the Blink of an Eye (p. 252)
  • Reduced Productivity Not Explained by Revenue Shortfall, R&D Spending, or Lagging Innovation in Basic Science (p. 252)
  • No Decline in Overall R&D Spending in the Combined Biopharmaceutical Industry (p. 253)
  • What's the Problem-Is There a Solution and Is There a Bright Future? (p. 253)
  • Caught in the Headlights (p. 256)
  • Bright Future? Unmet Need and Increased Global Demand Will Reshape The Industry (p. 257)
  • Origins of the Industry Reveal Some Insights into the Broken Pipeline Problem (p. 258)
  • Blossoming of Synthetic Organic Chemistry Creates the Pharmaceutical Industry (p. 258)
  • Low-Hanging Fruit and Limited Competition (p. 259)
  • Peaks Scaled but Still in the Foothills (p. 259)
  • Failure to Invest in Preventative Maintenance and Competitive Insurance (p. 260)
  • Winds of Change: New Technologies, New Innovators, and a New Product Class (p. 261)
  • Elements of a "Perfect Storm" (p. 261)
  • Innovation at Breakneck Speed Creates Confusion and Fear of Missing the IP Boat (p. 262)
  • Gusher for Patent Attorneys-Who Owns What and Can I Get a Piece of It? (p. 263)
  • Irrational Exuberance-High Cost, Low Quality (p. 264)
  • Mega-Mergers-Short-Term Fix That Derails Innovation and Productivity (p. 264)
  • Product Liability-Lighting Strikes That Kill the Golden Goose (p. 265)
  • New Kids on the Block-Generics and Biotech (p. 266)
  • Generics-Eroding a Fair Return on Investment or a Spur to Innovation in R&D and Patent Strategies? (p. 267)
  • Biotechs-The Upstarts Who Dared (p. 268)
  • High-Stakes IP Legal Battles Sharpen the Mind (p. 270)
  • Recasting the Game for an Even Bigger Win (p. 270)
  • Big Pharma Fights Back (or Not): Exploiting Innovation and IP Developed by Others (p. 271)
  • Failing to Exploit Technical Advantage (p. 271)
  • Do Recent Trends Predict Successful Stenting of the Pipeline? (p. 272)
  • Recent Cancer Success Indicates Innovation Is Alive and Well (p. 272)
  • Antibodies As Drugs-If at First You Don't Succeed... (p. 273)
  • New Cutting Edge but Lots of Room for Improvement (p. 274)
  • The Future: Personalized Medicine, Integrated Innovation, and Global Health (p. 274)
  • Global Health Issues (p. 276)
  • New Therapeutic Modalities-Soon to Be in the Spotlight (p. 276)
  • Conclusions (p. 278)
  • Bumpy Skies before Reaching Clear Air (p. 278)
  • 12. Building Companies on Not-So-Fertile Soil (Teri Willey) (p. 281)
  • Introduction (p. 281)
  • Impediments and Missing Pieces (p. 282)
  • Aligning the Interests of Stakeholders (p. 285)
  • Step by Step, Deal by Deal (p. 288)
  • Conclusion (p. 289)
  • Index (p. 291)
Content provided by Syndetic Solutions, Inc. Terms of Use
Title Summary
In this book for corporate executives and intellectual property managers, Kahn and fellow IP experts discuss how recent legislation affects global innovation issues and recommends strategies to help technology companies adapt to and thrive in these conditions. Issues affecting innovation and IP include the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights, the changing speed of technology, the dissolving of country borders, the decline of central corporate research and development in America, and the commoditization of technology. Case studies, statistics, and real-world anecdotes support advice on navigating these challenges through creative leadership, the harvesting of new intellectual assets, better management of innovation teams, and the development of growth strategies, among other methods. Annotation ©2007 Book News, Inc., Portland, OR (booknews.com)
Content provided by Syndetic Solutions, Inc. Terms of Use

Contact Us919-660-5870
(Perkins Circulation Desk)